Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amos Pasternack

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Kidney International|February 19, 2002
Polymorphism of the cytokine genes and IgA nephropathyJaana Syrjänen, Mikko Hurme, Terho Lehtimäki, et al.
Rheumatology (Oxford, England)|March 24, 2011
Novel carbonic anhydrase autoantibodies and renal manifestations in patients with primary Sjogren's syndromeMarja Pertovaara, Fatemeh Bootorabi, Marianne Kuuslahti, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 5, 2003
Cost analysis of renal replacement therapies in FinlandTapani Salonen, Tuomo Reina, Heikki Oksa, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 3, 2004
The effect of isolated ultrafiltration on Doppler-derived indices of left ventricular diastolic functionSeppo Ojanen, Vesa Virtanen, Tiit Kööbi, et al.
Nephron. Clinical Practice|November 12, 2005
High serum C3 predicts poor outcome in IgM nephropathyJuhani Myllymäki, Heikki Saha, Amos Pasternack, et al.
Nephron. Clinical Practice|March 10, 2007
Implications of levels of serum mineral metabolism markers, albumin and C-reactive protein for treatment costs of patients on maintenance dialysisTapani Salonen, Juho Piirto, Tuomo Reina, et al.
Duodecim; Laaketieteellinen Aikakauskirja|September 18, 2002
[Popular treatment recommendations]Minna Kaila, Osmo Saarelma, Jan Lindgren, et al.
Duodecim; Laaketieteellinen Aikakauskirja|August 26, 2004
[IGM nephropathy]Juhani Myllymäki, Heikki Saha, Heikki Helin, et al.
International Urology and Nephrology|March 3, 2007
Alternative strategies to evaluate the cost-effectiveness of peritoneal dialysis and hemodialysisTapani Salonen, Tuomo Reina, Heikki Oksa, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 29, 2003
IgM nephropathy: clinical picture and long-term prognosisJuhani Myllymäki, Heikki Saha, Jukka Mustonen, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Kidney International|February 19, 2002
Polymorphism of the cytokine genes and IgA nephropathyJaana Syrjänen, Mikko Hurme, Terho Lehtimäki, et al.
Rheumatology (Oxford, England)|March 24, 2011
Novel carbonic anhydrase autoantibodies and renal manifestations in patients with primary Sjogren's syndromeMarja Pertovaara, Fatemeh Bootorabi, Marianne Kuuslahti, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 5, 2003
Cost analysis of renal replacement therapies in FinlandTapani Salonen, Tuomo Reina, Heikki Oksa, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 3, 2004
The effect of isolated ultrafiltration on Doppler-derived indices of left ventricular diastolic functionSeppo Ojanen, Vesa Virtanen, Tiit Kööbi, et al.
Nephron. Clinical Practice|November 12, 2005
High serum C3 predicts poor outcome in IgM nephropathyJuhani Myllymäki, Heikki Saha, Amos Pasternack, et al.
Nephron. Clinical Practice|March 10, 2007
Implications of levels of serum mineral metabolism markers, albumin and C-reactive protein for treatment costs of patients on maintenance dialysisTapani Salonen, Juho Piirto, Tuomo Reina, et al.
Duodecim; Laaketieteellinen Aikakauskirja|September 18, 2002
[Popular treatment recommendations]Minna Kaila, Osmo Saarelma, Jan Lindgren, et al.
Duodecim; Laaketieteellinen Aikakauskirja|August 26, 2004
[IGM nephropathy]Juhani Myllymäki, Heikki Saha, Heikki Helin, et al.
International Urology and Nephrology|March 3, 2007
Alternative strategies to evaluate the cost-effectiveness of peritoneal dialysis and hemodialysisTapani Salonen, Tuomo Reina, Heikki Oksa, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 29, 2003
IgM nephropathy: clinical picture and long-term prognosisJuhani Myllymäki, Heikki Saha, Jukka Mustonen, et al.
Pageof 6